AzTrials
AzTrials

Paediatric BronchiectasisCASTLENCT07728006

The Development of Paediatric Bronchiectasis Quality of Life Questionnaires for Four Demographic Groups: Children 8-12years, Young People 13 - 17 Years and Parent Proxy Versions for Ages 2-5years and 6-12years

An observational study of Paediatric Bronchiectasis, run by Birmingham Women's and Children's NHS Foundation Trust at 1 site in United Kingdom.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

To develop and refine a disease-specific quality of life (QoL) questionnaire for children with bronchiectasis, informed by qualitative interviews with affected children, young people, and their parents. Read more about this study

Who is it for?
Ages 2 years and older
Conditions the study is for
Paediatric Bronchiectasis
How many people
78 participants
Where
1 siteUnited Kingdom
Study dates
30 Jul 2026to 30 Sep 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients aged 2years to 17 years with a CT diagnosis of Paediatric Bronchiectasis -unrelated to CF or PCD. Also parents of children and young people aged 2years-12years with a CT diagnosis of Paediatric Bronchiectasis -unrelated to CF or PCD.

Who may be able to join

  • Patient, child and young persons, aged 8 -17 years with bronchiectasis diagnosed on CT scan
  • Parent of child aged 2-12 years with bronchiectasis diagnosed on CT scan
  • Written informed consent/assent available

Who cannot join

  • Child under 8 years with bronchiectasis for patient direct participation
  • No consent/assent received
  • Confirmed Cystic Fibrosis or Primary Ciliary Dyskinesia diagnosis

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United Kingdom1 site
  • Birmingham Womens and Childrens NHS Foundation Trust

    Birmingham, B4 6NH

Other trials in United Kingdom

About this study

Official title: The Development of Paediatric Bronchiectasis Quality of Life Questionnaires

To develop and refine a disease-specific quality of life (QoL) questionnaire for children with bronchiectasis, informed by qualitative interviews with affected children, young people, and their parents.

The paediatric bronchiectasis- specific quality of life (PQOL-B) questionnaire will be developed across four demographics:

Children aged 8-12 years

Young people aged 13 -17 years

Parent-proxy for 2-5years

Parent-proxy for 6-12years

Read the detailed description

To develop and refine a disease-specific quality of life (QoL) questionnaire for children with bronchiectasis, informed by qualitative interviews with affected children, young people, and their parents.

The paediatric bronchiectasis- specific quality of life (PQOL-B) questionnaire will be developed across four demographics:

  1. Children aged 8-12 years
  2. Young people aged 13 -17 years
  3. Parent-proxy for 2-5years
  4. Parent-proxy for 6-12years

The development of the questionnaires will be carried out by conducting two different stages of interviews over a 12- month time period:

  1. Concept Elicitation - Semi structured interviews - will be to talk about what life is like living with bronchiectasis or living with a child who has bronchiectasis.
  2. Cognitive testing interviews - Once investigators create a first draft of the PQOL-B questionnaire, investigators will ask children, young people, and parents to try it out. In these interviews, investigators will ask if the questions make sense, are easy to understand, and feel relevant. This helps us refine and improve the questionnaire.

Recruitment and Interview Participants will be recruited from existing bronchiectasis database at the Birmingham Children's Hospital. Clinicians involved in routine care will screen eligible patients using pre-defined criteria.

Ideally new participants will be recruited for the second phase of the development of PQOL-B's where possible. But due to the rarity of the disease this may not always be possible to achieve. So, there may be some participants that will participate in both interview stages.

Consenting for interviews Potential participants will be provided with an age-appropriate participant information sheet and given adequate time to consider participation. Informed consent will be obtained from parents/guardians, and assent from children where appropriate - those 15years and younger.

Stage 1: Semi structured Interviews A schedule of open-ended questions has been developed to support data collection, with reference to existing literature and shaped by the research objectives.

Discussions will centre on participants' life experiences living with bronchiectasis or having a child diagnosed with the disease, the impact it has on daily living activities.

Individual, semi-structured open-ended interviews will be conducted where possible in person, or by a virtual online meeting (via Microsoft teams' platform) in accordance with participant preference, by the research team who have extensive training and experience in conducting qualitative interviews as well as extensive experience of working with children and their families living with bronchiectasis.

Interviews will be conducted by the research team and last approximately 45- 60 minutes, depending on how much the participant has to say.

Whether the interview is conducted in person or via video-call using Microsoft Teams, in accordance with participant preference, both ways will be recorded using the Microsoft Team's platform.

The recordings will be transcribed verbatim by the research team. The data will be accessible to the research team only, and investigators will only be sharing the anonymized transcripts for content analysis which includes an external collaborator as apart of the multi-disciplinary team, and this is for their expert academic input. Content analysis will be facilitated using NVivo software and will identify key themes, symptoms and impacts.

Ensuring no new information is emerging, and therefore saturation has been achieved.

Agreement on question selection and wording will be agreed during multi-disciplinary team discussions; these discussions will also include the results from a previously completed e-Delphi study, creating prototype of questionnaires ready for cognitive testing.

Stage 2: Cognitive testing Interview It is necessary to pre-test the prototype on the target population. Data will be collected using cognitive testing via an interview process. These Interviews will last approximately 45 minutes, depending on how much the participant has to say.

The method of the cognitive testing interview is as follows; Participants should complete the prototype PQOL-B using the instructions provided. Children must have the prototypes read to them.

After they have completed each section, they must complete a cognitive debriefing interview. The questions will be asked after each section and will seek to examine what the participants thought of the questions and why they choose their rating of each item.

Participants will be asked whether there were any words they did not understand or if any important content or impacts of bronchiectasis were missed.

The interviewer will record the interview via Microsoft Team's platform. The interview can be virtual or face to face interview, as per the patients/care givers preference. Any suggestion for change will be discussed with the research team. The recordings will be transcribed verbatim by the research team. The data will be further anonymised and will be accessible to the research team only, and an external collaborator for their expert academic input.

The results of the interviews will be used to form a translated final version of PQOL-B, ready for formal validation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Life questionnaires for paediatric Bronchiectasis

    Scale: Quality of Life questionnaires for paediatric Bronchiectasis -Across 4 age and respondent questionnaires will be developed and testing on the population it is designed for.

    Minimum: Not reported Maximum: Not reported Higher score: Not reported/not applicable Time frame: 1 year

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2026
  2. Study start30 Jul 2026
  3. Primary completion30 Jul 2027 (estimated)
  4. Study completion30 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Other
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07728006
Sponsor's protocol ID
367491
Acronym
CASTLE
Status last verified
Oct 2026
First submitted
21 Jul 2026
Last updated
6 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Sex Participant age Ethnicity Age at diagnosis Years Time since diagnosis Years(SD) CT Scan - for confirmation of disease

Publications

  • Smith H, Yates D, Nagakumar P, Kenia P. Pediatric Bronchiectasis Quality-of-Life Questionnaire-What Does the Literature Say? Pediatr Pulmonol. 2026 Feb;61(2):e71490. doi: 10.1002/ppul.71490.

    PubMed 41689271

Questions about this trial

What is this clinical trial studying?

An observational study of Paediatric Bronchiectasis, run by Birmingham Women's and Children's NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Life questionnaires for paediatric Bronchiectasis (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07728006, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in